Your privacy, your choice

We use essential cookies to make sure the site can function. We also use optional cookies for advertising, personalisation of content, usage analysis, and social media.

By accepting optional cookies, you consent to the processing of your personal data - including transfers to third parties. Some third parties are outside of the European Economic Area, with varying standards of data protection.

See our privacy policy for more information on the use of your personal data.

for further information and to change your choices.

Skip to main content
Fig. 5 | BMC Cancer

Fig. 5

From: Deciphering a proliferation-essential gene signature based on CRISPR-Cas9 screening to predict prognosis and characterize the immune microenvironment in HNSCC

Fig. 5

Association between the PEGs signature and clinicopathological characteristics. Heatmap displaying the relationship between the PEGs signature and various clinicopathological features, including age, gender, clinical stage (T, N, M), lymphovascular invasion, perineural invasion, and survival status (a). Box plots illustrating the distribution of risk scores across different clinical subgroups (b). Abbreviations: PEGs, proliferation-essential genes

Back to article page